Novel Applications of 99mTc-Tetrofosmin Radiopharmaceutical Composition
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of the original patent to develop novel applications of 99mTc-tetrofosmin radiopharmaceutical composition in non-medical fields, including water quality monitoring, industrial pipeline maintenance, food spoilage detection, HVAC system contamination detection, and agricultural product quality control.
Background and Problem Solved
The original patent focused on the development of a stable radiopharmaceutical composition for diagnostic purposes. However, the limitations of the original patent lie in its narrow application scope. The present inventive concept addresses this limitation by exploring new applications of the 99mTc-tetrofosmin radiopharmaceutical composition in various industries, providing innovative solutions to pressing problems in these fields.
Detailed Description of the Inventive Concept
The new claims describe systems and methods that utilize the 99mTc-tetrofosmin radiopharmaceutical composition in novel ways. For instance, Claim 1 describes a system for monitoring water quality in aquaculture, where the radiopharmaceutical composition is used to detect bacterial contamination. Claim 2 outlines a method for detecting biofilm formation in industrial pipelines, involving the use of the radiopharmaceutical composition to image the pipeline surface. Similarly, Claims 3-5 detail devices and methods for monitoring food spoilage, detecting microbial contamination in HVAC systems, and detecting fungal growth in agricultural products, all leveraging the 99mTc-tetrofosmin radiopharmaceutical composition.
Novelty and Inventive Step
The novelty of the new claims lies in their application of the 99mTc-tetrofosmin radiopharmaceutical composition to entirely new fields and problems. The inventive step is in recognizing the potential of this composition to provide innovative solutions in non-medical industries, and developing systems and methods that effectively utilize this technology.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different radiopharmaceutical compositions, or the integration of additional sensors or detection methods to enhance the accuracy and efficiency of the systems and methods described. Variations of the inventive concept could also involve adapting the technology for use in other industries or applications, such as environmental monitoring or biotechnology research.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including aquaculture, industrial maintenance, food processing, HVAC systems, and agriculture. The market demand for innovative solutions in these fields is substantial, and the adoption of the 99mTc-tetrofosmin radiopharmaceutical composition-based technology could provide a competitive edge to companies operating in these industries.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K51/0478 |
| A | A61 | A61K9/19 |
| A | A61 | A61K31/66 |
| A | A61 | A61K51/025 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Radiopharmaceutical composition and detection technologies, encompassing medical imaging, sensor systems, and molecular detection techniques. Requires advanced knowledge in radiochemistry, pharmaceutical formulation, sensor design, and interdisciplinary application of radioactive tracers
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree (PhD/MS) in radiochemistry, pharmaceutical sciences, or biomedical engineering. Possesses expertise in radioisotope manipulation, molecular detection techniques, and cross-disciplinary technology transfer
Obviousness Rationale
A PHOSITA would recognize the inherent detection capabilities of 99mTc-tetrofosmin composition based on its molecular binding and imaging properties. The source patent's detailed radiopharmaceutical formulation provides a clear technological foundation for exploring alternative detection applications. The compositional stability and specificity demonstrated in the medical context naturally suggest potential for broader sensing and detection technologies across multiple domains.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,647 |
|---|---|
| Title | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof |
| Assignee(s) | Jubilant Draximage Inc. |